This ruling is procedurally final and has no material impact on AstraZeneca's stock or operations. No further trading action warranted based on this filing.
AZN drugs
AZN drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 19 $164.95entry
- T+1 · 3mo ago −0.28%α +0.56% · $164.49
- T+5 · 3mo ago +0.80%α +1.19% · $166.27
- T+20 · 2mo ago +0.72%α +1.56% · $166.14
- T+60 · 4d ago +12.45%α +13.27% · $185.48
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
The U.S. District Court for the District of Maryland denied plaintiff Monique Richards Smith's motion to alter or amend judgment in an ADA discrimination and retaliation suit against AstraZeneca Pharmaceuticals LP. The court had previously granted summary judgment to AstraZeneca, and the denial of this post-judgment motion confirms that the case remains closed with no liability for the company.
Court Ruling Details
Key Facts
- The Court granted AstraZeneca's motion for summary judgment on all ADA claims on March 17, 2026.
- Plaintiff's motion to alter or amend judgment (Rule 59(e)) was denied on August 18, 2026.
- The case involves a single former employee's individual claims, no class action, no material financial exposure, and no business impact.
- AstraZeneca's market cap is ~$248.3B, making any potential damages in this routine employment case immaterial.
Financial Impact
No damages awarded or sought stated in the opinion; a routine single-plaintiff employment discrimination case with no financial exposure relative to AstraZeneca's size.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-fafddc1e09-AZN |
Track record
77 reports on AZN
19 of 38 bullish or bearish reports moved the stock their way by T+5. Best: +20.72% at T+60 after the Aug 17, 2026 report. 29 of 38 went positive at some point.
Filters
- Nov 16, 2026today 6-K Bullish 6/10 Entry price pending
- Nov 16, 2026today 6-K Bullish 6/10 Entry $185.55 Now $184.02 −0.82% settles Nov 23
- Nov 16, 2026today 6-K Bullish 6/10 Entry $185.31 Now $184.02 −0.70% settles Nov 23
- Nov 16, 2026today 6-K Bullish 5/10 Entry $185.09 Now $184.02 −0.58% settles Nov 23
- Nov 4, 202611d ago Institutional Cluster Mixed 3/10 Entry $186.85 to $184.38 Now $184.02 −1.51% ▼ −1.32% −4.61% vs SPY
- Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.02 −1.37% ▲ +1.51% +1.43% vs SPY
- Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.02 −1.37% ▲ +1.51% +1.43% vs SPY
- Oct 30, 202617d ago 6-K Neutral 5/10 Entry $186.65 to $186.43 Now $184.02 −1.41% ▼ −0.12% +2.59% vs SPY
- Oct 27, 202620d ago 6-K Bullish 5/10 Entry $170.08 to $183.88 Now $184.02 +8.20% ▲ +8.11% +10.10% vs SPY
- Oct 22, 202625d ago 6-K Bullish 6/10 Entry $172.57 to $173.46 Now $184.02 +6.63% ▲ +0.51% −0.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers